Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
Regional Anesthesia and Analgesia: Their Role in Postoperative Outcome
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
182-192
Author(s):
G. Ekatodramis
Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
171-199
Author(s):
Zafar H. israili
G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
139-151
Author(s):
J. Theilade, S. Haunso and S. P. Sheikh
Nonviral Gene Therapy
Journal:
Current Gene Therapy
Volume:
1
Page:
201-226
Author(s):
Song Li and Zheng Ma
Coagulation Factor Xa Inhibition: Biological Background and Rationale
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
151-159
Author(s):
Robert J. Leadley and Jr.
Small Heat Shock Proteins (sHSPs) As Potential Drug Targets
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
77-111
Author(s):
M. James C. Crabbe and Henry W. Hepburne-Scott
Chemical and Pharmacological Aspects of Heteroaryl-Nitrones
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1255-1267
Author(s):
Solo Goldstein and Pierre Lestage
Adenosine Receptor Ligands-Recent Developments Part I. Agonists
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1269-1288
Author(s):
C. E. Muller
New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Journal:
Current Drug Targets
Volume:
1
Page:
285-296
Author(s):
Imrana Qawi and Simon C. Robson